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In ‘normal’ conditions, pain triggered by a small lesion is
less intense and disappears in shorter time than after a large
lesion, which represents the expression of a major biological
protection mechanism to preserve organism integrity [1].
This proportionality between lesion and pain can be mod-
ified during intense emotional and cognitive situations [2].
Moreover, pain associated to diseases has the biological
protective function of restricting body activities and con-
centrating organism efforts on body healing. These adapta-
tive conditions result largely from brain modulation of
spinal nociceptive transmission [3,4], an endogenousmechanism that can be modulated by reciprocal commu-
nications between the BRAINSTEM (see glossary) and spinal
cord [4–8]. However, a prolonged pain condition can induce
brain and spinal neuroplasticity associated to CENTRAL SENSI-
TIZATION (see glossary) [9,10]. The resulting changes in neu-
ronal properties can lead to a deregulation of the brain
mechanisms modulating pain, which may account for the
maintenance of CHRONIC PAIN (see glossary) long after lesion
healing.
Endogenous pain control system
The PAG–RVM-dorsal horn circuitry
Although changes in pain behavior have been demonstrated
by manipulation of several brain areas, the main pain control
centers are located in the brainstem. The mesencephalic
periaqueductal grey (PAG) and the rostral ventromedial
medulla (RVM) are known for long to be implicated in
endogenous pain control through an antinociceptive
PAG–RVM-dorsal horn descending circuitry [11] (Fig. 1a).
However, increasing evidences also implicate the RVM in
descending facilitation of spinal nociceptive transmission
[9,11]. This dual effect is correlated with the co-existence at
the RVM of neurons involved in descending antinociceptive
actions (OFF-cells), along with cells responsible for
descending pronociceptive effects (ON-cells) (Fig. 1a).305
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Glossary
Allodynia: pain due to a stimulus that does not normally provoke pain.
Brainstem: the portion of the brain consisting of the medulla
oblongata, pons and mesencephalon. It is the major route for
communication between the forebrain and the spinal cord and controls
various functions including respiration and regulation of heart rhythms.
It includes the part of the reticular formation that plays a central role in
bodily and behavioral alertness.
Central sensitization: increased excitability of central pain-
transmitting neurons that may result from prolonged nociceptive
barrage and involves descending nociceptive modulation from the brain.
Chronic pain: pain that persists beyond resolution of an underlying
disorder or healing of an injury, and that is often more intense than the
underlying process would predict.
Forebrain: the most anterior segment of the adult brain that develops
from the embryonic telencephalon and diencephalon and includes the
cerebrum (cortex, hippocampus, amygdala), thalamus and
hypothalamus.
Hyperalgesia: an increased response to a stimulus that is normally
painful.
Limbic system: a group of interconnected deep brain structures
common to all mammals that includes the hypothalamus, amygdala,
olfactory bubs and hippocampus. It plays an important role in the
regulation of motivation, emotions and various autonomic functions.
Neuropathic pain: pain initiated or caused by a primary lesion or
dysfunction in the nervous system.
NK1 receptors: receptors for ligation of substance P, one of the main
neurotransmitters released by primary afferent nociceptive fibers in the
spinal dorsal horn.
NMDA receptors: subtype of Glutamate receptors involved in
synaptic potentiation at several neural pathways, including the pain
system. Their activation at spinal synapses leads to facilitation of post-
synaptic responses and enhanced neurotransmitter release and is
implicated in central sensitization and chronic pain mechanisms.
Peripheral sensitization: increased excitability of peripheral
nociceptors (primary afferents), often mediated by an inflammatory
process.Forebrain modulation of pain: role of the brainstem
Pain is a multidimensional experience where the sensory-
discriminative information conveyed from the periphery by
the nociceptive system is integrated with the emotional
environment processed by the amygdala (AMY) and cogni-
tive information concerning past experiences specific for
each individual [12]. The motivational-affective component
of the pain experience suggests that LIMBIC areas (see glossary)
like the AMY, the insular cortex (INS) and the anterior
cingulated cortex (ACC) should have the capacity to regulate
the endogenous pain control system and the final pain
perception. These FOREBRAIN areas (see glossary) are highly
interconnected and output nuclei have neurons with long
projecting axons terminating in areas like the PAG and RVM
(Fig. 1). Several areas of the caudal medulla oblongata
involved in pain modulation like the dorsal reticular nucleus
(DRt), the caudal ventrolateral medulla (CVLM) and the
nucleus tractus solitarius (NTS) are also targeted by the
forebrain, which indicates that emotions and cognition
can directly control brainstem areas implicated in nocicep-
tive modulation (Fig. 1). Accordingly, depending on306 www.drugdiscoverytoday.comenvironmental and emotional conditions, the AMY, INS
and ACC may exert a dual facilitating and inhibiting role
in pain modulation [13,14] mediated by caudal brainstem
areas, such as the RVM and DRt [13].
The caudal medulla oblongata
The caudalmost portion of the brainstem has several areas
involved in pain modulation. Besides the DRt [3,15,16],
CVLM [6] and NTS [17] referred above, it arbors other pain
control centers like the ventral reticular [16] and paratrigem-
inal nuclei [18]. Like the RVM, the caudal medulla oblongata
exerts a dual descending modulatory action by inhibiting or
increasing nociception. Thus, the caudal medulla oblongata
contributes to the fine balance between facilitation and
inhibition of spinal nociceptive transmission and, ultimately,
to pain perception. However, the descending modulatory
actions exerted by the DRt and the CVLM exhibit special
characteristics because they are conveyed by reciprocal
monosynaptic spino–bulbo–spinal loops. Besides allowing
rapid and dynamic pain modulation, these feedback loops
may allow that sudden changes of the nociceptive home-
ostasis triggers an adequate response of both medullary and
spinal nociceptive neurons. On the basis of the extensive
characterization of the brain connections of the DRt and
CVLM, it is likely that the brainstem–spinal reciprocal loops
also integrate nociception with other types of physiological
information arriving from the periphery and important for
body homeostasis.
The dorsal reticular nucleus
The brain–DRt–spinal circuitry is now well characterized
[3,19] and several studies indicate that the DRt is implicated
in nociceptive processing and modulation (Fig. 2a) [3,15]:
DRt neurons are exclusively or mainly activated by cutaneous
or visceral noxious stimulation; the DRt receives projections
from spinal dorsal horn nociceptive neurons that establish
asymmetrical, potentially excitatory, synaptic contacts with
DRt neurons projecting back to the dorsal horn [3]; DRt
neurons project to the dorsal horn and modulate spinal
nociceptive activation [16] by establishing asymmetrical
synapses with spinal neurons projecting back to the DRt.
These data indicate that a reciprocal excitatory feedback loop
occurs between the DRt and spinal dorsal horn, through
which ascending nociception is increased by the descending
branch of the circuit [3]. Moreover, DRt neurons project to
[19] and receive projections from [3] brain areas implicated in
the direct or indirect control of spinal nociceptive transmis-
sion, such as the CVLM, NTS, PAG, RVM, AMY, locus coeruleus
(noradrenergic antinociceptive centre) and paraventricular
hypothalamic nucleus (PVN – the main effector of the
physiological response to stress). This suggests that reciprocal
feedback loops occur not only between the DRt and the spinal
cord but also between the DRt and brainstem and forebrain
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neously to the spinal dorsal horn and the medial thalamus,
an area that allows direct access to the neocortex [20]. This
indicates that balanced nociception achieved by the DRt–
spinal cord interaction can reach forebrain areas implicated
in the affective dimension of pain.
The extensive ascending and descending connections with
forebrain, brainstem and spinal areas implicated in pain
processing and modulation supports the pain facilitating
[3,16] and pain inhibiting [15] actions attributed to the
DRt (Fig. 2a), as well as its role as a relay station mediating
pain modulation triggered by the neocortex [13].
The caudal ventrolateral medulla
The characterization of reciprocal connections between the
CVLM and the spinal cord suggested a special role of its
lateralmost part- the VLMlat- in pain modulation [6]. The
VLMlat targets exclusively spinal layers involved in nocicep-
tive transmission, namely laminae I, IV–V and X, and receives
nociceptive input from laminae I–III [6]. That the VLMlat is
the CVLM region more relevant in pain modulation is in
agreement with data showing that the hypoalgesia induced
following VLMlat stimulation is more pronounced and long
lasting than from other CVLM regions [6]. A closed reciprocal
loop connects the VLMlat with lamina I (Fig. 2b) and the
synaptic characterization of the loop suggests that the
ascending nociceptive input triggers descending modulation
mainly by inhibitory mechanisms and, in a lower extension,
facilitatory (see glossary) actions [6]. These observations pos-
tulated that the CVLM could also be involved in pronocicep-
tive effects, which was recently supported by the
demonstration of coexistence of ON and OFF cells in the
CVLM [21]. The functional relevance of the spino-VLMlat-
spinal loop was demonstrated by the differential involvement
of different types of lamina I neurons projecting to the
VLMlat and by different nociceptive activation of these neu-
ronal types after VLMlat lesions [6].
Descending modulation from the CVLM is dynamically
conveyed by direct and indirect complex circuits. The
a2-adrenoreceptor mediated inhibition of spinal nociceptive
transmission exerted by the CVLM is conveyed by the pon-
tine A5 noradrenergic cell group, whereas descending sero-
tonergic modulation appears to involve the RVM [6]. Besides
the A5 noradrenergic cell group and the RVM, other brain
regions are probably recruited in the descending modulation
from the CVLM because this area targets pain control centers
like the PAG, parabraquial area and locus coeruleus (Fig. 2b).
The pattern of CVLM connections in the brain further sug-
gests that it may play an important role in the integration of
pain responses with other body functions. The CVLM parti-
cipates in pain-cardiovascular integration and in the hypoal-
gesia detected during hypertensive conditions [22,23].
Finally, the arrival of spinal nociceptive input to the CVLMis also integrated with the information derived from wide-
spread brain areas [24]. The CVLM receives strong input from
areas participating in somatosensory processing, and auto-
nomic and motor controls. More than just providing a
mechanism of feedback integration, the reciprocal spino-
CVLM loop is likely to play a complex role on the protective
homeostatic function of the pain system.
Chronic pain and the brainstem–spinal dorsal horn
communication
Importance of controlling nociceptive input to the brain
Acute pain and transient ALLODYNIA and HYPERALGESIA (see
glossary) associated to inflammation, chronic pain and
disease are crucial examples of the importance of pain
for organism protection (Fig. 1). Conversely, other situa-
tions require analgesia to preserve organism integrity and
surviving, which indicates that pain suppression is as
important to the organism as pain perception [2]. Fear
and acute stress, for example, strongly inhibit pain as it
could be incompatible with the need of running from
eminent danger. Accordingly, the AMY and the PVN, areas
responsible for emotional processing of fear and initiation
of the physiological response to stress, respectively, have
shown to modulate pain [25,26].
Recent data indicate that the analgesic action triggered by
PVN stimulation changes the activity of ON and OFF cells also
present in the RVM and CVLM [21,27], which is exerted
through a descending serotonergic and noradrenergic path-
way inhibiting spinal nociceptive neurons (unpublished).
These PVN actions upon the medulla oblongata and spinal
cord are paralleled by a correspondent inhibition of pain-like
behavior [21,27]. The AMY exerts also a fine control upon
RVM ON and OFF cell activities, and the data collected
indicate that the AMY is also implicated in pain facilitation
[26,28]. Finally, the ACC, a key area in the processing of the
motivational-affective dimension of pain was also shown to
have a descending nociceptive facilitating action, which is
mediated by two relay medullary centers, the RVM and the
DRt [13] (Fig. 2a). All these data strongly implicate medul-
lary pronociceptive and antinociceptive centers reciprocally
connected with the spinal dorsal horn, as relay stations for
the pain modulatory actions triggered by forebrain areas
regulating pain experience. Importantly, the induction of
chronic pain can change the modulatory action of the
forebrain upon brainstem neurons and, consequently, upon
and spinal neurons and nociceptive transmission (Fig. 1b).
This was recently demonstrated for the PVN, as its actions
upon RVM and CVLM ON and OFF cells and spinal con-
vergent nociceptive neurons changed after the development
of arthritis [21,27]. Thus, prolonged pain states are capable
of changing the physiological homeostasis of the forebrain–
brainstem–spinal cord neuronal network implicated in pain
modulation.www.drugdiscoverytoday.com 307
Drug Discovery Today: Disease Mechanisms | Pain Vol. 3, No. 3 2006
Figure 1. Schematic representation of the supraspinal endogenous pain control system following physiological (a) and chronic (b) pain. Ascending pain
pathways (red arrows) convey nociception to different targets along the brain, including the major brainstem pain modulating areas. Descending
neuronal projections (blue arrows) between brain areas relevant for descending pain control extend from the forebrain to the spinal cord dorsal
horn. Under physiological conditions (a) the RVM contains nociceptive neurons that project to the spinal dorsal horn and facilitate (+: ON-cells) or
inhibit (: OFF-cells) spinal nociceptive transmission arriving from peripheral nociceptors (green arrow). Pain chronification (b) resulting from
peripheral (large green arrow) and central (large red arrows) sensitization induces changes in the endogenous pain control system, which
may include disruption of the antinociceptive system (: dashed blue arrow) and exacerbation of pronociceptive mechanisms (+: large blue arrow).
Changes induced at forebrain levels are less known and are represented by blurred blue arrows. It should be noted that the RVM plays also a
role in the noradrenergic descending control mediated by the locus coeruleus (DLPT). The three-dimensional rat brain profiles at the left of
1a and 1b represent the levels of the brain coronal sections A–D. A–D are central nervous system sections adapted with permission from the
Paxinos and Watson Atlas [41] and represent the spinal dorsal horn (A), the medulla oblongata and pons (B), the mesencephalon (C) and the
308 www.drugdiscoverytoday.com
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Table 1. Medullary-spinal circuitries: roles in pain perception and potential future therapies for chronic pain treatment
Brainstem–spinal
circuit
Strategic approach
to the circuit
Expected outcome
of intervention
at the circuit
Who is
working in
the circuit
Potential
therapies
Advantages/
disadvantages
of these therapies
Refs
DRt–spinal - DRt chemical or
electrical stimulation
or inhibition
Pronociception -
increased
(DRt stimulation) or
decreased
(DRt inhibition)
pain behaviour
Almeida, A et al.
[3,16,19]
- Gene therapy
(GT)
(GT): Induction of local
production of opioid
drugs/very preliminary
studies
[3,15,16,
19,20,
33,35]
- DRt local
administration
of drugs
Tavares, I et al.
[33,35]
- Intracerebral
lesioning (ICL)
(ICL): Potential block
of pronociception in
chronic pain processing/
Location between two
respiratory areas
Villanueva et al.
[15,20]
ACC–DRt–spinal Stimulation/lesioning
the ACC and DRt,
respectively
Pronociceptive
modulation mediated
by he limbic system
Zhang, L et al.
[13]
? ? [13]
CVLM–spinal - Local chemical or
electrical stimulation
or inhibition
Antinociception –
decreased
pain behaviour
Tavares, I et al.
[6,22–24]
- Gene therapy Induction of opioid
production by CVLM-
spinal neurons/very
preliminary studies and
motor and respiratory
side effects
[6,21–24]
- Local administration
of drugs
Pertovaara, A and
Almeida, A [21]
- C-fos visualization of
nociceptive neurons
NTS–spinal - NTS lesioning Sickness-induced
hyperalgesia
Watkins, LR and
Maier, SF [17]
? ? [17]
- proinflammatory
cytokines
RVM–spinal - Local administration
of drugs
Pronociception and/or
Antinociception
Porreca, F et al.,
[5,9,32]
- Ablation of opioid
RVM cells
- Reduction of neuropathic
pain/neuronal death
[5,7,9,11,
31,32]
- Destruction of substance
P spinal neurons
Dickenson, A, [7] - Cholecystokinin
antagonists
- Prevention of opioid
tolerance
- Excitatory transmitter
release
Fields, H,
Heinricher, M, [11] - NMDA antagonists
Dubner, R et al.
[31]
- Serotonergic pain-
facilitating pathways
AMY–RVM–spinal - Local administration
of opioids
Antinociception
mediated by the
limbic system
Heinricher et al.
[26]
? ? [26]
PVN–RVM–spinal - Local chemical stimulation
or inhibition
Stress-induced
analgesia
Pertovaara, A and
Almeida, A [27]
? ? [27]
- Local administration
of drugsRole of the brainstem in the development of chronic pain
Chronic inflammatory or NEUROPATHIC PAIN (see glossary)
results from prolonged nociceptive barrage to the central
nervous system and the resulting neuroplasticity of periph-
eral and central components of the nociceptive system.
Central and PERIPHERAL SENSITIZATION (see glossary) increase
neuronal excitability along the ascending and descending
pain pathways, which may disrupt the fine balance between
pronociceptive and antinociceptive pain modulatory actions
descending from the brain [4,29]. The reciprocal anatomicalforebrain (diencephalon and telencephalon), (D). Abbreviations: ACC, anterior ci
dorsal reticular nucleus; Hyp, hypothalamus; DLPT, dorsolateral pontine tegme
ventromedial medulla.connections between the medulla oblongata and the spinal
cord should play a role on neuronal plasticity of brainstem
and spinal dorsal horn areas and in the impairment of pain
behavior in chronic pain syndromes. Accordingly, the RVM
and PAG are involved in human central sensitization [30],
whereas in the rat the RVM is implicated in the maintenance
of central sensitization in persistent inflammatory, neuro-
pathic and visceral pain states [9,31] (Fig. 1b). The RVM is also
responsible for the increased release of nociceptive neuro-
transmitters by peripheral nociceptors in the spinal dorsalngulate cortex; AMY, amygdala; CVLM. caudal ventrolateral medulla; DRt,
ntum; Ins, insular cortex; PAG, periaqueductal gray matter; RVM, rostral
www.drugdiscoverytoday.com 309
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Figure 2. Spino-bulbo-spinal and brain neuronal network underlying the DRt (a) and the CVLM (b) involvement in pain modulating circuitries. In what
concerns the DRt (a) note the reciprocal connections with the spinal dorsal horn, Hyp, PAG and RVM. The DRt has a pronociceptive action upon the
spinal nociceptive transmission arriving from the front paw dermatome submitted to strong noxious stimulation (+ in the neuron located at the spinal level
stimulated by hammering the forepaw) [3]. Moreover, it appears to mediate the inhibition of heterotopic nociception ( in the neuron located at the
spinal level stimulated by pricking the hindpaw dermatome), a phenomenon known as diffuse noxious inhibitory control (DNIC) (see reference [15] for details).
The limbic system projects massively to the DRt. In what concerns the CVLM (b), note the large afferent projections from several cortical, subcortical
and diencephalic areas of the brain and the reciprocal connections with the PAG, parabrachial nuclei, RVM and spinal cord. Ascending connections
are represented in red, descending projections are in blue and nociceptors are depicted in green. A–D are central nervous system sections adapted with
permission from the Paxinos and Watson Atlas [41] and represent the spinal dorsal horn (A), the medulla oblongata and pons (B), the mesencephalon (C) and
the forebrain (diencephalon and telencephalon, D). Abbreviations: A5, A5 noradrenergic cell group; ACC, anterior cingulate cortex; AMY, amygdala;
CVLM. caudal ventrolateral medulla;DRt, dorsal reticular nucleus; Hyp, hypothalamus; Infral, limbic cortex; Ins, insular cortex; Mot, Motor cortex; NTS, nucleus
tractus solitarius; PAG– periaqueductal gray matter; PB, parabrachial nuclei; RVM, rostral ventromedial medulla, Som, somatosensory cortex; Th, thalamus.
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ficial dorsal horn projection neurons expressing neurokinin-1
receptors (NK1-R) (see glossary), which are activated by exci-
tatory neurotransmitters released by peripheral nociceptors,
control spinal excitability and pain sensitivity through brain-
stem serotonergic facilitatory pathways descending along the
dorsolateral funiculus [7,8]. Interestingly, the expression of
NK1-R in spinal neurons projecting to brainstem areas
involved in pain modulation differs with the target as the
expression of NK1-R in the spino-CVLM pathway is stronger
than that in the spino-DRt, which appears to exhibit mainly
GABAB receptors [33].
The role of the two reciprocal bulbospinal loops centered at
the DRt and VLMlat in inflammatory and chronic inflamma-
tory pain is only beginning to be addressed. In both pain
models the activity of the DRt was shown to be increased [34].
During arthritis, a strong decrease in the expression of GABAB
and m-opioid receptors in DRt and CVLM nociceptive neu-
rons was demonstrated ([35], unpublished), which might
account for a lower efficacy of drugs acting upon these
receptor systems. Accordingly, the intensity of nociceptive
neuronal activation at the CVLM is negatively correlated with
nociceptive activation of lamina I neurons (unpublished).
Finally, we have recently demonstrated an involvement of
both spinomedulllary loops in the differential expression of
NK1 and GABAB receptors in spinal nociceptive neurons
during secondary hyperalgesia induced by arthritic pain
(unpublished). These data demonstrate the importance of
controlling the cross talk between the brainstem and spinal
cord in pain perception. Accordingly, the endogenous anti-
nociceptive pain control system is disrupted in a dysfunc-
tional pain syndrome like fibromyalgia and may account for
the generalized hypersensitivity shown by these patients [10].
Conclusions
The brainstem concentrates all regions directly modulating
the ascending nociceptive transmission from the spinal dor-
sal horn and mediates the pain control orders triggered by the
forebrain areas responsible for coordination of the final pain
perception. Moreover, the brainstem (and the medial thala-
mus) is also the main recipient of the spinal nociceptive
information concerning the motivational-affective dimen-
sion of pain. This indicates that the brainstem and spinal
cord are privileged areas for assuming the permanent home-
ostasis of the nociceptive system and its integration with
other body functions through a continuous balance mediated
by reciprocal feedback loops.
Can a better knowledge of the brainstem-spinal crosstalk
be used in future therapies for pain control? On the basis of
the extensive connections of pain control centers and on
their involvement in several body functions, the search for
neuronal specific targets of manipulation should be envi-
saged (Table 1). Gene therapy with vectors that target specificneurons and deliver therapeutic transgenes, like opioid pre-
cursors, in an inducible and sustained manner could be
important in the future. The reciprocal bulbospinal loops
implicated in pain control could be targeted by spinal admin-
istration of viral vectors that migrate to the caudal medulla.
Thus, future therapies aimed at specifically increasing the
serotonergic and noradrenergic descending control and the
opioidergic, GABAergic and glycinergic ‘pain’ inhibiting
action at the spinal level may prove effective in providing
analgesia. On the contrary, neuroinflammatory factors invol-
ving not only neuronal networks but also glial cells and the
immune system are actually under intense research in studies
involving mainly chronic neuropathic pain models. How-
ever, no data are available on how the reciprocal networks
between the brainstem and spinal cord are affected by the
immune and glial changes accompanying prolonged inflam-
mation and chronification of pain. Finally, a potential ther-
apeutical target involving crosstalk between the brain and
spinal cord could be the development of more specific drugs
for modulating wind-up and long term potentiation (LTP) in
spinal neurons following pain syndromes [36]. These two
mechanisms induce increased/prolonged activity of nocicep-
tive neurons/excitatory synapses and are implicated in cen-
tral sensitization at both the brain and dorsal horn levels.
Thus, they are both potentially present in supraspinally
projecting spinal nociceptive neurons and nociceptive brain-
stem neurons modulating spinal nociceptive transmission.
Reinforcing the necessity of exploring this hypothesis, endo-
genous spinal opioid receptors were shown to play a role in
the endogenous spinal opioid mechanisms involved in wind-
up [37], whereas GABA and NMDA RECEPTORS (see glossary)
participate in spinal LTP induction and maintenance
[38,39]. Future studies at the molecular level concerning
the identification of specific characteristics of the pain neu-
ronal network and improvement of membrane receptor cel-
lular biology [40] are needed to develop well localized
targeting strategies to control pain. However, although pro-
mising and exciting, the power of controlling the feedback
interactions between the brain and spinal cord in terms of
pain mechanisms is conceptually and technically complex
and far from being achieved [38].
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